Comparable Survival Outcomes with Haploidentical Stem Cell Transplantation and Cord Blood Transplantation

Scientists identified 136 patients aged between 16 and 69 years who received HLA-haploidentical stem cell transplantation using post-transplant cyclophosphamide as their first transplantation for acute leukemia or myelodysplastic syndromes.